Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8463474 | 0.84 | HDAC4 (0.30) | — | |
| SCHEMBL5400361 | 0.84 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL2963209 | 0.84 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL2962376 | 0.84 | GAA (0.40) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL16678854 | 0.82 | — | — | |
| SCHEMBL5697706 | 0.82 | GAA (0.39) | GAAKDM4EL3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL5048328 | 0.82 | GAA (0.42) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL28996662 | 0.82 | MAOB (0.37) | GAAKDM4EKMT2A | |
| SCHEMBL870336 | 0.81 | GAA (0.38) | GAAKDM4EL3MBTL1KMT2A | |
| SCHEMBL7044879 | 0.79 | GBA1 (0.43) | GAAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885L3MBTL1 3957/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885KDM4E 2885/4885L3MBTL1 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.